| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/02/2002 | US20020052011 Method for evaluating and affecting male fertility |
| 05/02/2002 | US20020052000 Diagnostics for and mediators of inflammatory disorders |
| 05/02/2002 | US20020051984 Nucleotide sequences coding cell proliferation protein; for use in the treatment of cancer, wounds, inflammation, arthritis, psoraisis, vision and cell proliferation defects |
| 05/02/2002 | US20020051976 Methods and compositions for polypeptide engineering |
| 05/02/2002 | US20020051969 Modulatory polypeptide; for use in the treatment of bone disorders |
| 05/02/2002 | US20020051793 Lipoteichoic acid immunogenic compositions and methods of making and using thereof |
| 05/02/2002 | US20020051787 Steroids, viricides, and anti-microbial neutralizing antibodies suspended in a carrier |
| 05/02/2002 | US20020051785 HER -2/neu overexpression abrogates growth inhibitory pathways |
| 05/02/2002 | US20020051784 Methods for modulating T cell unresponsiveness |
| 05/02/2002 | US20020051782 Anti-CCR2 antibodies and methods of use therefor |
| 05/02/2002 | US20020051781 CC-chemokine receptor 2 (CCR2) bound by an immunoglobulin or an antigen-binding fragment |
| 05/02/2002 | US20020051780 Bind at the same time to the T-cell receptor complex, to tumour- associated antigens on a tumour cell, and, via the Fc portion of the bispecific antibody |
| 05/02/2002 | US20020051751 Therapy using the Mossbauer absorption phenomenon; pharmaceuticals containing radiation absorber isotope are administered and then excited; results in radiolysis of DNA resulting in lethal breaks in DNA molecules of target tissue |
| 05/02/2002 | EP1201757A2 Method for preparing water soluble polypeptides |
| 05/02/2002 | EP1201756A2 Method for preparing water soluble polypeptides |
| 05/02/2002 | EP1200602A1 Dsp-11 dual-specificity map kinase phophatase |
| 05/02/2002 | EP1200596A2 Human synthetases |
| 05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
| 05/02/2002 | EP1200591A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 05/02/2002 | EP1200590A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 05/02/2002 | EP1200587A2 Receptors and associated proteins |
| 05/02/2002 | EP1200586A2 Human nervous system-associated proteins |
| 05/02/2002 | EP1200585A1 T-cell receptor gamma alternate reading frame protein, (tarp) and uses thereof |
| 05/02/2002 | EP1200584A1 Splice variants of cd40-receptor |
| 05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/02/2002 | EP1200562A2 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 05/02/2002 | EP1200479A1 Multiple cytokine-antibody complexes |
| 05/02/2002 | EP1200477A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 05/02/2002 | EP1200476A1 Antitumor antibodies, proteins, and uses thereof |
| 05/02/2002 | EP1200475A1 Diagnostic method using expression of mn/ca9 protein in ascus pap smears |
| 05/02/2002 | EP1200474A1 Human g-protein coupled receptor |
| 05/02/2002 | EP1200469A2 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 05/02/2002 | EP1200467A1 Novel human calcium sensitive potassium channel subunits |
| 05/02/2002 | EP1200466A2 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosisesat-6 gene family |
| 05/02/2002 | EP1200126A1 Use of cd28 specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections |
| 05/02/2002 | EP1200125A1 Psca: prostate stem cell antigen and uses thereof |
| 05/02/2002 | EP1200124A1 Immunoglobulin fusion proteins |
| 05/02/2002 | EP1200123A1 Diagnosis and treatment of neuroectodermal tumors |
| 05/02/2002 | EP1200121A2 Fish vaccine |
| 05/02/2002 | EP1200120A1 Pneumococcal vaccines |
| 05/02/2002 | EP1200113A2 Reagents and methods useful for detecting diseases of the prostate |
| 05/02/2002 | EP1200098A2 Combined preparations comprising daunorubicin derivatives and anti her2 antibodies |
| 05/02/2002 | EP0593585B1 Peptide which abrogates tnf and lps toxicity |
| 05/02/2002 | DE10050935A1 Verwendung CD28 spezifischer monoklonaler Antikörper zur Stimulation von Blutzellen, welche kein CD28 tragen Using CD28 monoclonal antibody specific for the stimulation of blood cells, which carry no CD28 |
| 05/02/2002 | CA2457111A1 Vaccine for treating allergy |
| 05/02/2002 | CA2427312A1 Engineered chimera of protein fragments and methods of use thereof |
| 05/02/2002 | CA2427085A1 Transmembrane proteins |
| 05/02/2002 | CA2427070A1 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | CA2427024A1 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | CA2426779A1 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| 05/02/2002 | CA2426767A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | CA2426465A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/02/2002 | CA2426463A1 Novel aggrecanase molecules |
| 05/02/2002 | CA2426405A1 Estrogen receptor alpha variants and methods of detection thereof |
| 05/02/2002 | CA2426321A1 Mfq-114, a human ajuba like protein |
| 05/02/2002 | CA2425897A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | CA2425000A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections |
| 05/02/2002 | CA2422953A1 Identification and modification of immunodominant epitopes in polypeptides |
| 05/01/2002 | CN1347326A BAFF, inhibitors thereof and their use in modulation of B-cell response |
| 04/30/2002 | US6380376 Purity polypeptides |
| 04/30/2002 | US6380374 Isolated nucleic acid; culture product |
| 04/30/2002 | US6380372 Barley gene for Thioredoxin and NADP-thioredoxin reductase |
| 04/30/2002 | US6380371 Endoglycan: a novel protein having selectin ligand and chemokine presentation activity |
| 04/30/2002 | US6380365 Temperature dependent ligand facilitated purification of proteins |
| 04/30/2002 | US6380363 Antibodies to the Ob receptor |
| 04/30/2002 | US6380360 Polycystic kidney disease 1 gene and uses thereof |
| 04/30/2002 | US6380161 Therapy of cancer, wherein a cancer chemotherapy agent is selected, conjugated to peptide, and one dose is administered to patient in therapeutically effective amount, and wherein peptide binds to a receptor for thrombospondin |
| 04/30/2002 | US6379975 Methods and reagents for determining protein S |
| 04/30/2002 | US6379953 An activated leukocyte cell adhesion molecule bearing mesenchymal stem cell; for accelerating differentiation of bone morphogenic proteins; bone repair therapy |
| 04/30/2002 | US6379925 Angiogenic modulation by notch signal transduction |
| 04/30/2002 | US6379913 A polypeptide encoding an amino acid sequence; prevention and therapy for diabetes, inflammatory glomerulonephritis, ischemis renal failure, artherosclerosis, coronary vasoconstriction and ischemic heart disease |
| 04/30/2002 | US6379907 Detecting cancerous cervical lesions from atypical glandular cells of undetermined significance papanicolaou smear cells based on the presence of a specific antigen not found in atypical cells, but present on normal endocervical cells |
| 04/30/2002 | US6379905 Fragments of prion proteins |
| 04/30/2002 | US6379902 Mycrobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
| 04/30/2002 | US6379901 Detecting cancer cells that express a human leukocyte antigen molecule using a nonapeptide derived from the tumor rejection antigen precursor; mixing cells and nonapeptide to form complexes; expose to cytolytic cells and determine lysis |
| 04/30/2002 | US6379891 A polymerase chain reaction amplification method for detecting enterically transmitted non-a/non-b viral hepatitis in a biological sample |
| 04/30/2002 | US6379708 Method for enhancing immune responses in mammals |
| 04/30/2002 | US6379699 Liposome having attached target-binding moiety and artherosclerotic plaque interacting moiety |
| 04/30/2002 | US6379671 Using a polypeptide antigen mixture |
| 04/30/2002 | US6379669 Drug delivery to prostate gland |
| 04/30/2002 | US6379668 Therapy for autoimmune disease |
| 04/30/2002 | US6379667 Medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction |
| 04/30/2002 | US6379666 TNF inhibitors for the treatment of neurological, retinal and muscular disorders |
| 04/30/2002 | US6379661 Pharmaceutical compositions comprising pluripotent granulocyte colony-stimulating factor |
| 04/30/2002 | CA2151045C Platelet-activating factor acetylhydrolase |
| 04/30/2002 | CA2128784C Large, latent complexes of tgf-beta2 and tgf-beta3 |
| 04/30/2002 | CA2071908C Antibody antagonists of human interleukin-4 |
| 04/30/2002 | CA2047997C Antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
| 04/30/2002 | CA2020247C Antibodies reactive with human carcinomas |
| 04/25/2002 | WO2002033119A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 04/25/2002 | WO2002033114A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2002033113A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2002033112A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2002033101A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 04/25/2002 | WO2002033099A2 Human kinases |
| 04/25/2002 | WO2002033092A1 Gene sp17 inhibiting lesion formation in plant and utilization thereof |
| 04/25/2002 | WO2002033086A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | WO2002033083A2 Methods of using a human il-17-related polypeptide to treat disease |
| 04/25/2002 | WO2002033079A2 Human g-protein coupled receptor and uses thereof |
| 04/25/2002 | WO2002033074A1 Artificial protein having potentiated immunogenicity of epitope |